International recognition for IBG’s Parkinson’s research
The project led by Prof. Dr. Güneş Özhan, Group Leader at the Izmir Biomedicine and Genome Center (IBG), has been awarded funding under the 2515-COST Scientific and Technological Cooperation Programme.
Prof. Özhan’s project, titled “Investigation of the Anti-Inflammatory and Neuroprotective Role of Wnt/ß-Catenin Signaling in Parkinson’s Disease Using the Zebrafish Model”, will be conducted within the scope of the COST Action “The role of IMMUnity in tackling PARKinson's disease through a Translational NETwork (IMMUPARKNET)”.
The study aims to elucidate the role of the Wnt/ß-catenin signaling pathway in the pathogenesis of Parkinson’s disease and to explore its anti-inflammatory and neuroprotective functions using the zebrafish model. The research is expected to contribute to identifying novel therapeutic targets for Parkinson’s disease.
PhD student Dilek Nazlı and Hüseyin Güner from IBG-BIP Bioinformatics Platform will also take part in the project alongside Prof. Özhan.